NWF Advisory Services’s Novo Nordisk NVO Stock Holding History

NWF Advisory Services’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$264K	Buy	7,194 +1,103	+18%	+$52.3K	0.03%	317
2025 Q4	$310K	Sell	6,091 -1,046	-15%	-$53.5K	0.03%	280
2025 Q3	$396K	Sell	7,137 -681	-9%	-$39.9K	0.04%	239
2025 Q2	$540K	Buy	+7,818	New	+$532K	0.06%	196
2024 Q4	–	Sell	-3,892	Closed	-$463K	–	377
2024 Q3	$463K	Buy	3,892 +1,758	+82%	+$234K	0.07%	176
2024 Q2	$305K	Buy	2,134 +276	+15%	+$36.6K	0.05%	218
2024 Q1	$239K	Buy	+1,858	New	+$221K	0.04%	257

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

NWF Advisory Services's NVO Position: Q1 2026 in Review

NWF Advisory Services increased its Novo Nordisk (NVO) stake by 18% in Q1 2026, buying an estimated $52.3K and bringing the position to 7,194 shares worth $264K. The position accounts for 0.03% of the portfolio, ranked #317.

NWF Advisory Services first reported a position in NVO in Q1 2024 and has held it in 7 quarters since. The position peaked at $540K in Q2 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

NWF Advisory Services held 7,194 shares of Novo Nordisk worth $264K as of Q1 2026.
NWF Advisory Services bought 1,103 Novo Nordisk shares in Q1 2026, an estimated $52.3K.
Novo Nordisk made up 0.03% of NWF Advisory Services's portfolio in Q1 2026, its #317 holding.
NWF Advisory Services first reported a position in Novo Nordisk in Q1 2024 and has held it in 7 quarters since.
NWF Advisory Services's Novo Nordisk position peaked at $540K in Q2 2025.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on NWF Advisory Services's 13F filing for Q1 2026, filed 4 May 2026.